Bio Preventive Medicine Corp. announced on December 8, 2023 that its IVD products, DNlite-DKD uPTM-FetA ELISA Kit (aka DNlite-IVD103-DKD) and DNlite-KT uPTM-FetA ELISA Kit (aka DNlite-IVD103-KT), have received MDMA approval from Saudi FDA. DNlite-IVD103-DKD is used as an aid in assessing the prognosis of kidney function in type 2 diabetes patients. DNlite-IVD103-KT is used as an aid in assessing the prognosis of kidney function in Kidney transplant patients. The new and improved DNlite-IVD103 kit has a shorter operating time and streamlined transportation conditions compared to the previous generation.
Currently we are looking for distribution partners in Saudi Arabia. Please contact dnlite@bpmbiotech.com if interested.